137 related articles for article (PubMed ID: 17372273)
21. Weak binding to E3 ubiquitin ligase c-Cbl increases EGFRvA protein stability.
Song F; Zhou M; Wang B; Shi B; Jiang H; Zhang J; Li Z
FEBS Lett; 2016 May; 590(9):1345-53. PubMed ID: 27059931
[TBL] [Abstract][Full Text] [Related]
22. EGF receptor ubiquitination is not necessary for its internalization.
Huang F; Goh LK; Sorkin A
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):16904-9. PubMed ID: 17940017
[TBL] [Abstract][Full Text] [Related]
23. Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase.
Li N; Lorinczi M; Ireton K; Elferink LA
J Biol Chem; 2007 Jun; 282(23):16764-75. PubMed ID: 17449471
[TBL] [Abstract][Full Text] [Related]
24. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
25. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases.
Oved S; Mosesson Y; Zwang Y; Santonico E; Shtiegman K; Marmor MD; Kochupurakkal BS; Katz M; Lavi S; Cesareni G; Yarden Y
J Biol Chem; 2006 Aug; 281(31):21640-21651. PubMed ID: 16735510
[TBL] [Abstract][Full Text] [Related]
26. Sulindac metabolites induce proteosomal and lysosomal degradation of the epidermal growth factor receptor.
Pangburn HA; Ahnen DJ; Rice PL
Cancer Prev Res (Phila); 2010 Apr; 3(4):560-72. PubMed ID: 20332299
[TBL] [Abstract][Full Text] [Related]
27. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor.
Waterman H; Levkowitz G; Alroy I; Yarden Y
J Biol Chem; 1999 Aug; 274(32):22151-4. PubMed ID: 10428778
[TBL] [Abstract][Full Text] [Related]
28. Two different stages of epidermal growth factor (EGF) receptor endocytosis are sensitive to free ubiquitin depletion produced by proteasome inhibitor MG132.
Melikova MS; Kondratov KA; Kornilova ES
Cell Biol Int; 2006 Jan; 30(1):31-43. PubMed ID: 16275144
[TBL] [Abstract][Full Text] [Related]
29. Mutant epidermal growth factor receptor undergoes less protein degradation due to diminished binding to c-Cbl.
Hosaka T; Inoue F; Ando K; Ishida H; Kusumoto S; Sugiyama T; Shirai T; Okuda K; Hirose T; Ohnishi T; Horichi N; Saijo N; Adachi M; Nakadate T; Kuroki T; Ohmori T
Anticancer Res; 2007; 27(4B):2253-63. PubMed ID: 17695511
[TBL] [Abstract][Full Text] [Related]
30. Differential roles of Grb2 and AP-2 in p38 MAPK- and EGF-induced EGFR internalization.
Grandal MV; Grøvdal LM; Henriksen L; Andersen MH; Holst MR; Madshus IH; van Deurs B
Traffic; 2012 Apr; 13(4):576-85. PubMed ID: 22192528
[TBL] [Abstract][Full Text] [Related]
31. Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII.
Pedersen MW; Pedersen N; Ottesen LH; Poulsen HS
Br J Cancer; 2005 Oct; 93(8):915-23. PubMed ID: 16189524
[TBL] [Abstract][Full Text] [Related]
32. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
[TBL] [Abstract][Full Text] [Related]
33. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
Visser GD; Lill NL
Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
[TBL] [Abstract][Full Text] [Related]
34. LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.
Stutz MA; Shattuck DL; Laederich MB; Carraway KL; Sweeney C
Oncogene; 2008 Sep; 27(43):5741-52. PubMed ID: 18542056
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain.
Huang F; Kirkpatrick D; Jiang X; Gygi S; Sorkin A
Mol Cell; 2006 Mar; 21(6):737-48. PubMed ID: 16543144
[TBL] [Abstract][Full Text] [Related]
36. Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells.
Fiori JL; Zhu TN; O'Connell MP; Hoek KS; Indig FE; Frank BP; Morris C; Kole S; Hasskamp J; Elias G; Weeraratna AT; Bernier M
Endocrinology; 2009 Jun; 150(6):2551-60. PubMed ID: 19213840
[TBL] [Abstract][Full Text] [Related]
37. Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII.
Han W; Zhang T; Yu H; Foulke JG; Tang CK
Cancer Biol Ther; 2006 Oct; 5(10):1361-8. PubMed ID: 16969069
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin and NEDD8: brothers in arms.
Schmidt MHH; Dikic I
Sci STKE; 2006 Nov; 2006(362):.pe50. PubMed ID: 17119158
[TBL] [Abstract][Full Text] [Related]
39. Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome.
Bao J; Alroy I; Waterman H; Schejter ED; Brodie C; Gruenberg J; Yarden Y
J Biol Chem; 2000 Aug; 275(34):26178-86. PubMed ID: 10816576
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradation.
Hoffman P; Carlin C
Mol Cell Biol; 1994 Jun; 14(6):3695-706. PubMed ID: 8196613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
